Stay updated on Embrace Watch Usability in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Embrace Watch Usability in Dravet Syndrome Clinical Trial page.

Latest updates to the Embrace Watch Usability in Dravet Syndrome Clinical Trial page
- Check6 days agoChange DetectedThe page changes from a 403 Forbidden screen to the ClinicalTrials.gov record for the Embrace seizure detection watch usability study, including its study details and posted results information.SummaryDifference41%

- Check13 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice announces that NIH agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedA 403 Forbidden page is displayed, replacing the study record content. The header and footer remain visible, indicating access is blocked.SummaryDifference17%

Stay in the know with updates to Embrace Watch Usability in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Embrace Watch Usability in Dravet Syndrome Clinical Trial page.